KLF
Krüppel-like factor (KLF) family members share a three C2H2 zinc finger DNA binding domain, and are involved in cell proliferation and differentiation control in normal as in pathological situations. KLFs can be deregulated in multiple cancers either by loss of heterozygosity (LOH), somatic mutation or transcriptional silencing by promoter hypermethylation.
KLF family member proteins play a critical role in the growth and metastasis of numerous tumor types, at least in part by regulating the expression of cell cycle genes. Globally, KLF4 and KLF6 are considered as tumor suppressor gene, whereas KLF5 promotes cell proliferation. Family members have different transcriptional properties and can modulate each other's activity by a variety of mechanisms. Since cells can express multiple KLFs, KLF transcription factors build likely a transcriptional network to control cell proliferation. Effects of changes in KLF factors are context-dependent and can appear contradictory, considering differences in the expression profile of family members in various cells. Last, KLF variants may antagonize the function of wild type proteins.
Targets for KLF
Products for KLF
- Cat.No. Nom du produit Informations
-
GC32692
APTO-253 (LOR-253)
APTO-253
APTO-253 (LOR-253) est une nouvelle petite molécule qui exerce une activité antitumorale puissante en induisant l'expression du gène du facteur de transcription maître Kruppel-like factor 4 (KLF4), inhibant ainsi le cycle cellulaire et conduisant à la mort cellulaire programmée. -
GC11307
ML-264
Le ML-264 est un agent antitumoral qui inhibe puissamment et sélectivement l'expression du facteur cinq de type Krüppel (KLF5).
-
GC64287
SR15006
SR15006 est un inhibiteur du facteur 5 de type KrÜppel (KLF5) avec une IC50 de 41,6 nM dans les cellules DLD-1/pGL4.18hKLF5p).